Journal of Nutrition,Fasting and Health

Journal of Nutrition,Fasting and Health

Effect of Intermittent Fasting during Ramadan on Visfatin, Adiponectin and Tumor necrotizing Factor- Alpha in Healthy Muslim Individuals

Document Type : Research Paper

Authors
Eisa Safavi 1
Ali Reza Rahbar 2
1 Department of Labaratory Technology, Paramedical Faculty, Bushehr University of Medical Sciences, Bushehr, I.R. Iran
2 Department of Nutrition, Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, I.R. Iran
10.22038/jfh.2017.22719.1084
Abstract
Introduction:The aim of this study was to investigate the effect of fasting in Ramadan on visfatin, tumor necrosis factor alpha (TNF-α) and adiponectin level in human. Methods:Thirty four men aged 24 to 55 years old were selected from those people who were willing to fast in Ramadan. The blood sample was obtained from each participant in fasting state at the beginning and the end of study to determine serum visfatin, adiponectin and TNF-α. Paired T test was used to identify differences between beginning and the end of the study in serum visfatin, adiponectin and TNF-α. Results:Results showed a significant decrease in Visfatin after study. There were no significant changes in adiponectin and TNF-α during Ramadan fasting. Conclusion:It is concluded that fasting in Ramadan is beneficial to health and can ameliorate some inflammatory markers in fasting individuals.
Keywords
Visfatin
Adiponectin
Tumor necrotizing factor- alpha
Ramadan fasting
  1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26.
  2. Ribeiro F, Alves AJ, Duarte JA, Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol. 2010; 141(3):214-21.
  3. Bulcão C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF. The new adipose tissue and adipocytokines. Curr Diabetes Rev. 2006; 2(1):19-28.
  4. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006; 290(6):E1253-61.
  5. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care. 2003; 26(8):2442-50.
  6. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells. Biochim Biophys Acta. 2008; 1783(5):886-95.
  7. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis possible role in inflammation and plaque destabilization. Circulation. 2007; 115(8):972-80.
  8. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004; 89(6):2563-8.
  9. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002; 277(40):37487-91.
  10. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem. 2003; 278(4):2461-8.
  11. Barton A, John S, Ollier WE, Silman A, Worthington J. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum. 2001; 44(1):61-5.
  12. Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Rheumatology. 1996; 35(11):1067-74.
  13. Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R. Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol. 2007; 26(2):211-5.
  14. Michalsen A, Li C. Fasting therapy for treating and preventing disease-current state of evidence. Forsch Komplementmed. 2013; 20(6):444-53.
  15. Nair PM, Nanda A. Naturopathic medicine in India. Focus Alternat Complement Ther. 2014; 19(3):140-7.
  16. Shripathi Adiga H, Adiga RS. Concept and canons of fasting in Ayurveda. J Fast Health. 2013; 1(1):37-40.
  17. Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long‐term effects of calorie or protein restriction on serum IGF‐1 and IGFBP‐3 concentration in humans. Aging Cell. 2008; 7(5):681-7.
  18. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011; 35(5):714-27.
  19. Grossniklaus DA, O’Brien MC, Clark PC, Dunbar SB. Nutrient intake in heart failure patients. J Cardiovasc Nurs. 2008; 23(4):357.
  20. Elliott B, Mina M, Ferrier C. Complete and voluntary starvation of 50 days. Clin Med Insights Case Rep. 2016; 9:67-70.
  21. Godavarthy P, Kumari YS, Bikshapathy E. Starvation induced cholesterogenesis in hepatic and extra hepatic tissues of climbing Perch, Anabas testudineus (Bloch). Saudi J Biol Sci. 2012; 19(4):489-94.
  22. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008; 27(6):793-9.
  23. Faris MA, Kacimi S, Al-Kurd RA, Fararjeh MA, Bustanji YK, Mohammad MK, et al. Intermittent fasting during Ramadan attenuates proinfla
    mmatory cytokines and immune cells in healthy subjects. Nutr Res. 2012; 32(12):947-55.
  24. Consultation WE. Waist circumference and waist-hip ratio. Report of a WHO Expert Consultation. Geneva: World Health Organization; 2008. P. 8-11.
  25. Mitterberger MC, Mattesich M, Klaver E, Lechner S, Engelhardt T, Larcher L, et al. Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction. J Gerontol A Biol Sci Med Sci. 2010; 65(9):915-23.
  26. Kang ES, Magkos F, Sienkiewicz E, Mantzoros CS. Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans. Eur J Endocrinol. 2011; 164(6):911-7.
  27. Owczarek AJ, Olszanecka-Glinianowicz M, Kocelak P, Bozentowicz-Wikarek M, Brzozowska A, Mossakowska M, et al. The relationship between circulating visfatin/nicotinamide phosphoribo
    syltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling. Scand J Clin Lab Invest. 2016; 76(8):632-40.
  28. Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J, Garcia-Serrano S, Rivas-Marin J, Gallego-Perales JL, et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring). 2007; 15(10):2391-5.
  29. Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front Neuroen
    docrinol. 2010; 31(3):377-93.
  30. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab. 1997; 82(11):3647-54.
  31. Tan BK, Chen J, Brown J, Adya R, Ramanjaneya M, Menon V, et al. In vivo and ex vivo regulation of visfatin production by leptin in human and murine adipose tissue: role of mitogen-activated protein kinase and phospha
    tidylinositol 3-kinase signaling pathways. Endocrinology. 2009; 150(8):3530-9.
  32. Chowdhury EA, Richardson JD, Tsintzas K, Thompson D, Betts JA. Effect of extended morning fasting upon ad libitum lunch intake and associated metabolic and hormonal responses in obese adults. Int J Obes. 2016; 40(2):305-11.
  33. Khoshdel A, Kheiri S, Nasiri J, Tehran HA, Heidarian E. The effect of Ramadan fasting on serum leptin, neuropeptide Y and insulin in pregnant women. Med J Islam Repub Iran. 2014; 28:92.
  34. Razeghi Jahromi S, Ghaemi A, Alizadeh A, Sabetghadam F, Moradi Tabriz H, Togha M. Effects of intermittent fasting on experimental autoimune encephalomyelitis in C57BL/6 mice. Iran J Allergy Asthma Immunol. 2016; 15(3):212-9.
  35. Vasconcelos AR, Yshii LM, Viel TA, Buck HS, Mattson MP, Scavone C, et al. Intermittent fasting attenuates lipopolysaccharide-induced neuroinfla
    mmation and memory impairment. J Neuroinflammation. 2014; 11:85.
  36. Feizollahzadeh S, Rasuli J, Kheirouri S, Alizadeh M. Augmented plasma adiponectin after prolonged fasting during Ramadan in men. Health Promot Perspect. 2014; 4(1):77-81.
  37. Bahammam A. Does Ramadan fasting affect sleep? Int J Clin Pract. 2006; 60(12):1631-7.
  38. Lahdimawan A, Handono K, Indra MR, Prawiro SR. Effect of Ramadan fasting on endorphin and endocannabinoid level in serum, PBMC and macrophage. Int J Pharm Sci Invent. 2013; 2(3):46-54.
  39. Lin J, Shen Y, Gao Y, Li L. beta-Endorphin enhances IL-2 and IFN-gamma gene expression in human blood mononuclear cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997; 19(5):353-6.
  40. Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003; 88(4):1730-6.
  41. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 2004; 219(1):9-15.
  42. Wan R, Ahmet I, Brown M, Cheng A, Kamimura N, Talan M, et al. Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats. J Nutr Biochem. 2010; 21(5):413-7.
Journal of Nutrition,Fasting and Health
Volume 5, Issue 2
Spring 2017
Pages 50-55

  • Receive Date 27 March 2017
  • Revise Date 18 May 2017
  • Accept Date 21 May 2017